Department of Mechanical Engineering, University of Utah, Salt Lake City, Utah, United States of America.
Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
PLoS One. 2018 Mar 15;13(3):e0193180. doi: 10.1371/journal.pone.0193180. eCollection 2018.
Zebrafish are a valuable model organism in biomedical research. Their rapid development, ability to model human diseases, utility for testing genetic variants identified from next-generation sequencing, amenity to CRISPR mutagenesis, and potential for therapeutic compound screening, has led to their wide-spread adoption in diverse fields of study. However, their power for large-scale screens is limited by the absence of automated genotyping tools for live animals. This constrains potential drug screen options, limits analysis of embryonic and larval phenotypes, and requires raising additional animals to adulthood to ensure obtaining an animal of the desired genotype. Our objective was to develop an automated system that would rapidly obtain cells and DNA from zebrafish embryos and larvae for genotyping, and that would keep the animals alive. We describe the development, testing, and validation of a zebrafish embryonic genotyping device, termed "ZEG" (Zebrafish Embryo Genotyper). Using microfluidic harmonic oscillation of the animal on a roughened glass surface, the ZEG is able to obtain genetic material (cells and DNA) for use in genotyping, from 24 embryos or larvae simultaneously in less than 10 minutes. Loading and unloading of the ZEG is performed manually with a standard pipette tip or transfer pipette. The obtained genetic material is amplified by PCR and can be used for subsequent analysis including sequencing, gel electrophoresis, or high-resolution melt-analysis. Sensitivity of genotyping and survival of animals are both greater than 90%. There are no apparent effects on body morphology, development, or motor behavior tests. In summary, the ZEG device enables rapid genotyping of live zebrafish embryos and larvae, and animals are available for downstream applications, testing, or raising.
斑马鱼是生物医学研究中一种有价值的模式生物。它们快速的发育、模拟人类疾病的能力、用于测试下一代测序中发现的遗传变异的效用、对 CRISPR 诱变的适应性以及治疗化合物筛选的潜力,导致它们在广泛的研究领域得到了广泛的应用。然而,由于缺乏用于活体动物的自动化基因分型工具,它们进行大规模筛选的能力受到限制。这限制了潜在的药物筛选选项,限制了对胚胎和幼虫表型的分析,并需要饲养额外的动物至成年,以确保获得所需基因型的动物。我们的目标是开发一种自动化系统,该系统能够快速从斑马鱼胚胎和幼体中获取细胞和 DNA 进行基因分型,并保持动物存活。我们描述了一种名为“ZEG”(斑马鱼胚胎基因分型器)的斑马鱼胚胎基因分型设备的开发、测试和验证。该设备利用动物在粗糙玻璃表面上的微流谐波振荡,能够在不到 10 分钟的时间内同时从 24 个胚胎或幼体中获取用于基因分型的遗传物质(细胞和 DNA)。ZEG 的加载和卸载通过标准移液器吸头或移液管手动进行。获得的遗传物质通过 PCR 扩增,可用于后续分析,包括测序、凝胶电泳或高分辨率熔解分析。基因分型的灵敏度和动物的存活率均大于 90%。对身体形态、发育或运动行为测试没有明显影响。总之,ZEG 设备能够快速对活体斑马鱼胚胎和幼体进行基因分型,并且动物可用于下游应用、测试或饲养。